CAH vs ABBV
Based on Invest's signal, Cardinal Health, Inc. (CAH) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus hold for ABBV.
| Metric | CAH | ABBV |
|---|---|---|
| Price | $228.03 | $259.36 |
| Day change | +0.9% | +0.9% |
| Market cap | $53.4B | $458.2B |
| P/E ratio | 40.9 | 127.8 |
| 1-year return | +44.5% | +36.1% |
| Invest signal | Buy | Hold |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying CAH and ABBV at live prices.
CAH vs ABBV: FAQ
Is CAH or ABBV the better stock to buy?
Based on Invest's signal, Cardinal Health, Inc. (CAH) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus hold for ABBV. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, CAH or ABBV?
ABBVIE INC. is the larger company by market capitalisation ($458.2B vs $53.4B).
Can I practice trading CAH and ABBV for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both CAH and ABBV at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.